| 92.55 -3.86 (-4%) | 04-10 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 115.71 |
1-year : | 125.64 |
| Resists | First : | 99.07 |
Second : | 107.56 |
| Pivot price | 91.14 |
|||
| Supports | First : | 85.33 | Second : | 70.99 |
| MAs | MA(5) : | 93.72 |
MA(20) : | 92.34 |
| MA(100) : | 108.11 |
MA(250) : | 92.03 |
|
| MACD | MACD : | -3 |
Signal : | -4.3 |
| %K %D | K(14,3) : | 80.4 |
D(3) : | 70.6 |
| RSI | RSI(14): 43.8 |
|||
| 52-week | High : | 123.8 | Low : | 65.57 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CURE ] has closed below upper band by 37.5%. Bollinger Bands are 28.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 97.44 - 98.1 | 98.1 - 98.64 |
| Low: | 90.94 - 91.56 | 91.56 - 92.07 |
| Close: | 91.75 - 92.76 | 92.76 - 93.59 |
The Direxion Daily Healthcare Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the performance of the Health Care Select Sector Index. There is no guarantee the fund will achieve its stated investment objectives.
Wed, 08 Apr 2026
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity (NYSEARCA:CURE) - Seeking Alpha
Tue, 07 Apr 2026
Why Is Direxion Daily Healthcare Bull 3X ETF (CURE) Stock Down Today? - Meyka
Sun, 05 Apr 2026
Encompass Health (EHC) Soars 6.7% Intraday – What’s Fueling the Surge? - Bitget
Tue, 31 Mar 2026
Direxion Daily Healthcare Bull 3X Shares declares quarterly distribution of $0.2912 - MSN
Fri, 20 Mar 2026
Direxion Daily Healthcare Bull 3X Shares declares quarterly distribution of $0.3101 - MSN
Sun, 01 Feb 2026
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |